BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37822428)

  • 1. Correlation of Disease Activity Scores and Routine Assessment of Patient Index Data (RAPID3) on a Multidimensional Health Assessment Questionnaire in Patients With Rheumatoid Arthritis: A Saudi Experience.
    Abdulaziz S; Almaqati AS; Komo K; Alahmadi A
    Cureus; 2023 Sep; 15(9):e44982. PubMed ID: 37822428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
    Kim SK; Park SH; Bae J; Son JT; Choe JY
    Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
    Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
    Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T; Swearingen CJ; Bergman M; Yazici Y
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
    Pincus T; Swearingen CJ; Bergman MJ; Colglazier CL; Kaell AT; Kunath AM; Siegel EL; Yazici Y
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials.
    Bergman M; Buch MH; Tanaka Y; Citera G; Bahlas S; Wong E; Song Y; Zueger P; Ali M; Strand V
    Rheumatol Ther; 2022 Dec; 9(6):1517-1529. PubMed ID: 36125701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of MDHAQ for disease activity assessment in patients with rheumatoid arthritis].
    Yang M; Wang Y; Xie QB; Cen XR; Yin G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):285-8. PubMed ID: 25924447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
    Lee SW; Kim SY; Chang SH
    BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits.
    England BR; Barber CEH; Bergman M; Ranganath VK; Suter LG; Michaud K
    Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1809-1814. PubMed ID: 32813284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.
    Muñoz JGB; Giraldo RB; Santos AM; Bello-Gualteros JM; Rueda JC; Saldarriaga EL; Angarita JI; Arias-Correal S; Vasquez AY; Londono J
    Clin Rheumatol; 2017 May; 36(5):1143-1148. PubMed ID: 28013433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.
    Aletaha D; Nell VP; Stamm T; Uffmann M; Pflugbeil S; Machold K; Smolen JS
    Arthritis Res Ther; 2005; 7(4):R796-806. PubMed ID: 15987481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T
    Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
    Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
    Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.
    Smolen JS; Aletaha D
    Arthritis Rheum; 2011 Jan; 63(1):43-52. PubMed ID: 21204103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.
    Dhaon P; Das SK; Srivastava R; Dhakad U
    Int J Rheum Dis; 2018 Nov; 21(11):1933-1939. PubMed ID: 28608433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-cultural and clinical validation of the MDHAQ/RAPID3 questionnaire in electronic format for a Brazilian population of patients with rheumatoid arthritis.
    Lineburger IB; Brenol CV; Goularte AS; Pinheiro EP; Hirakata VN
    Adv Rheumatol; 2022 Nov; 62(1):46. PubMed ID: 36419141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.
    Eissa M; El Shafey A; Hammad M
    Clin Rheumatol; 2017 Oct; 36(10):2217-2224. PubMed ID: 28534075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition.
    Yokogawa N; Shimada K; Sugii S; Komiya A; Matsui T; Nishino J; Tohma S
    ACR Open Rheumatol; 2020 May; 2(5):301-306. PubMed ID: 32362072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.